SINGLETON, Andrew: Maryland/USA

Bios

Andrew Singleton received his B.Sc. from the University of Sunderland, UK and his Ph.D. from the University of Newcastle upon Tyne, UK. His postdoctoral studies were spent at the Mayo Clinic in Jacksonville Florida. He then moved to the National Institute on Aging at NIH Bethesda, MD. In 2008 he became the Chief of the Laboratory of Neurogenetics, and in 2016 he was named an NIH Distinguished Investigator. He has published more than 550 articles on a wide variety of topics. His laboratory comprises ~60 staff, including six principal investigators and three group leaders, working on the genetic basis of neurological disorders including Parkinson’s disease, Alzheimer’s disease, dystonia, ataxia, dementia with Lewy bodies, and amyotrophic lateral sclerosis.

He currently serves on the scientific advisory board of the Lewy Body Dementia Association. Andrew has won numerous prestigious awards including the Boehringer Mannheim Research Award, the NIH Director’s Award twice, the Annemarie Opprecht Award for Parkinson’s disease research, the Jay van Andel Award for Outstanding Achievement in Parkinson’s Disease Research, and the American Academy of Neurology Movement Disorders Award. Andrew was recently a proud recipient of an honorary doctorate from his alma mater, the University of Sunderland.